Paroxetine News
Findings on Antidepressants During Pregnancy Are Reason for Caution
Until recently, antidepressants—especially selective serotonin reuptake inhibitors (SSRIs)—were considered fairly safe for pregnant women. But late last year, citing evidence from several sources, the FDA warned that infants of...
Reexamining the Link between Antidepressants and Suicidality in Children and Adolescents.
In October 2004, the FDA mandated that a black box warning be added for all antidepressants used in children and adolescents-a move that sparked widespread concern about the use of these drugs.1 The FDA's decision followed...
Paroxetine treatment improves motor symptoms in patients with multiple system atrophy
Purpose: In view of the putative role of serotonergic neurotransmission in basal ganglia circuitry we investigated the effects of paroxetine (PXT) as a selective serotonin reuptake inhibitor (SSRI) on the motor performance in...
Drug Therapy Maintains Remission in Depressed Elderly Patients.
Extending antidepressant treatment of elderly patients beyond the commonly recommended 6 to 12 months was recently reported to be more effective than monthly psychotherapy in maintaining remission, with a lower relapse rate than...
Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine
A 71-year old man with failed back syndrome was admitted to hospital with oliguria that had occurred 4 days after his dose of paroxetine had been increased to 40 mg·day−1.